SUMMARY
The article presents an analysis of the consumption of drugs by patients with acute leukemia in specialized health institutions of Ukraine. A patient with acute lymphocytic leukemia by doctors was made almost twice as prescribing drugs than patients with acute myeloid leukemia. It was found that the structure of consumption of drugs dominated those names, which are necessary for pathogenetic treatment of acute leukemia. Thus, anticancer drugs are one of three leaders as the frequency of medical prescriptions and on the amount of consumption of drugs. More than half of the resources were spent on the consumption of drugs, which are essential to meet the requirements of the legal framework, which regulates the organization of medical and pharmaceutical process providing patients with hematological malignancies. Given the fact that the vast majority of patients belonged to socially vulnerable groups of the population, the introduction of effective mechanisms to compensate for the cost of the high-value of anticancer drugs is presented as the main direction of enhancing the efficiency of pharmaceutical provision patients with hematological malignancies.